Maharaja Agrasen Hospital

Delhi 110052

0 studies enrolling now · 2 studies all time

What they study most

Crohn's Disease, Dyslipidemia, Type2 Diabetes

Studies at this site

• Pemafibrate to Reduce Cardiovascular OutcoMes by Reducing Triglycerides IN patiENts With diabeTes (PROMINENT) — Stopped early
• Filgotinib in the Induction and Maintenance of Remission in Adults With Moderately to Severely Active Crohn's Disease — Completed